These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 20333450)
1. GPR56 plays varying roles in endogenous cancer progression. Xu L; Begum S; Barry M; Crowley D; Yang L; Bronson RT; Hynes RO Clin Exp Metastasis; 2010 Apr; 27(4):241-9. PubMed ID: 20333450 [TBL] [Abstract][Full Text] [Related]
2. GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2. Yang L; Friedland S; Corson N; Xu L Cancer Res; 2014 Feb; 74(4):1022-31. PubMed ID: 24356421 [TBL] [Abstract][Full Text] [Related]
3. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. Xu L; Begum S; Hearn JD; Hynes RO Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9023-8. PubMed ID: 16757564 [TBL] [Abstract][Full Text] [Related]
4. Crucial contribution of GPR56/ADGRG1, expressed by breast cancer cells, to bone metastasis formation. Sasaki SI; Zhang D; Iwabuchi S; Tanabe Y; Hashimoto S; Yamauchi A; Hayashi K; Tsuchiya H; Hayakawa Y; Baba T; Mukaida N Cancer Sci; 2021 Dec; 112(12):4883-4893. PubMed ID: 34632664 [TBL] [Abstract][Full Text] [Related]
5. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells. Yue Z; Yuan Z; Zeng L; Wang Y; Lai L; Li J; Sun P; Xue X; Qi J; Yang Z; Zheng Y; Fang Y; Li D; Siwko S; Li Y; Luo J; Liu M FASEB J; 2018 May; 32(5):2422-2437. PubMed ID: 29269400 [TBL] [Abstract][Full Text] [Related]
6. The G-protein coupled receptor 56, expressed in colonic stem and cancer cells, binds progastrin to promote proliferation and carcinogenesis. Jin G; Sakitani K; Wang H; Jin Y; Dubeykovskiy A; Worthley DL; Tailor Y; Wang TC Oncotarget; 2017 Jun; 8(25):40606-40619. PubMed ID: 28380450 [TBL] [Abstract][Full Text] [Related]
7. GPR56 in cancer progression: current status and future perspective. Yang L; Xu L Future Oncol; 2012 Apr; 8(4):431-40. PubMed ID: 22515446 [TBL] [Abstract][Full Text] [Related]
8. Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition. Luo W; Tan P; Rodriguez M; He L; Tan K; Zeng L; Siwko S; Liu M J Biol Chem; 2017 Sep; 292(37):15525-15537. PubMed ID: 28768769 [TBL] [Abstract][Full Text] [Related]
9. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation. Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935 [TBL] [Abstract][Full Text] [Related]
10. CD24 Is Not Required for Tumor Initiation and Growth in Murine Breast and Prostate Cancer Models. Cremers N; Neeb A; Uhle T; Dimmler A; Rothley M; Allgayer H; Fodde R; Sleeman JP; Thiele W PLoS One; 2016; 11(3):e0151468. PubMed ID: 26978528 [TBL] [Abstract][Full Text] [Related]
11. GPR56 Regulates VEGF production and angiogenesis during melanoma progression. Yang L; Chen G; Mohanty S; Scott G; Fazal F; Rahman A; Begum S; Hynes RO; Xu L Cancer Res; 2011 Aug; 71(16):5558-68. PubMed ID: 21724588 [TBL] [Abstract][Full Text] [Related]
12. GPR56 and its related diseases. Jin Z; Luo R; Piao X Prog Mol Biol Transl Sci; 2009; 89():1-13. PubMed ID: 20374731 [TBL] [Abstract][Full Text] [Related]
13. The adhesion G protein-coupled receptor GPR56 is a cell-autonomous regulator of oligodendrocyte development. Giera S; Deng Y; Luo R; Ackerman SD; Mogha A; Monk KR; Ying Y; Jeong SJ; Makinodan M; Bialas AR; Chang BS; Stevens B; Corfas G; Piao X Nat Commun; 2015 Jan; 6():6121. PubMed ID: 25607655 [TBL] [Abstract][Full Text] [Related]
14. GPR56/ADGRG1 Activation Promotes Melanoma Cell Migration via NTF Dissociation and CTF-Mediated Gα Chiang NY; Peng YM; Juang HH; Chen TC; Pan HL; Chang GW; Lin HH J Invest Dermatol; 2017 Mar; 137(3):727-736. PubMed ID: 27818281 [TBL] [Abstract][Full Text] [Related]
15. Agonistic antibodies reveal the function of GPR56 in human glioma U87-MG cells. Ohta S; Sakaguchi S; Kobayashi Y; Mizuno N; Tago K; Itoh H Biol Pharm Bull; 2015; 38(4):594-600. PubMed ID: 25832639 [TBL] [Abstract][Full Text] [Related]
16. Relaxin promotes prostate cancer progression. Feng S; Agoulnik IU; Bogatcheva NV; Kamat AA; Kwabi-Addo B; Li R; Ayala G; Ittmann MM; Agoulnik AI Clin Cancer Res; 2007 Mar; 13(6):1695-702. PubMed ID: 17363522 [TBL] [Abstract][Full Text] [Related]
17. Characterization of GPR56 protein and its suppressed expression in human pancreatic cancer cells. Huang Y; Fan J; Yang J; Zhu GZ Mol Cell Biochem; 2008 Jan; 308(1-2):133-9. PubMed ID: 17932623 [TBL] [Abstract][Full Text] [Related]
18. The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression. Song Y; Aglipay JA; Bernstein JD; Goswami S; Stanley P Cancer Res; 2010 Apr; 70(8):3361-71. PubMed ID: 20395209 [TBL] [Abstract][Full Text] [Related]
19. Mint3 in bone marrow-derived cells promotes lung metastasis in breast cancer model mice. Hara T; Murakami Y; Seiki M; Sakamoto T Biochem Biophys Res Commun; 2017 Aug; 490(3):688-692. PubMed ID: 28634075 [TBL] [Abstract][Full Text] [Related]
20. GPR56: An adhesion GPCR involved in brain development, neurological disorders and cancer. Ganesh RA; Venkataraman K; Sirdeshmukh R Brain Res; 2020 Nov; 1747():147055. PubMed ID: 32798453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]